tradingkey.logo

Treace Medical Concepts Inc

TMCI
3.360USD
-0.200-5.62%
收盤 11/11, 16:00美東報價延遲15分鐘
214.05M總市值
虧損本益比TTM

Treace Medical Concepts Inc

3.360
-0.200-5.62%

關於 Treace Medical Concepts Inc 公司

Treace Medical Concepts, Inc. 是一家醫療技術公司。該公司致力於提高拇囊炎和相關中足畸形的外科治療標準。該公司已獲得 Lapiplasty 3D 拇囊炎矯正系統的專利,該系統結合了器械、植入物和手術方法,旨在通過手術矯正拇囊炎畸形的所有三個平面並固定不穩定的關節,解決拇囊炎的根本原因並幫助患者恢復積極的生活方式。該公司還擁有 Adductoplasty 中足矯正系統,旨在對中足進行可重複的外科矯正,以及錘狀趾 PEEK 固定系統,旨在解決錘狀趾、爪形趾和槌狀趾畸形。Lapiplasty、Adductoplasty 和錘狀趾 PEEK 固定系統由一次性植入物套件和可重複使用的器械托盤組成。該公司將這些產品出售給美國的醫生、外科醫生、醫院和門診手術中心。

Treace Medical Concepts Inc簡介

公司代碼TMCI
公司名稱Treace Medical Concepts Inc
上市日期Apr 23, 2021
CEOMr. John T. Treace
員工數量477
證券類型Ordinary Share
年結日Apr 23
公司地址100 Palmetto Park Place
城市PONTE VEDRA
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編32081
電話19043735940
網址https://www.treace.com/
公司代碼TMCI
上市日期Apr 23, 2021
CEOMr. John T. Treace

Treace Medical Concepts Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
516.36K
+4.86%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
62.40K
-0.33%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
40.90K
+140.86%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
25.00K
-6.14%
Mr. Gaetano Guglielmino
Mr. Gaetano Guglielmino
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. John T. Treace
Mr. John T. Treace
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Aaron J. Berutti
Mr. Aaron J. Berutti
Senior Vice President - Sales
Senior Vice President - Sales
--
--
Mr. Mark L. Hair
Mr. Mark L. Hair
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Lynn Lewis
Ms. Lynn Lewis
Investor Relations
Investor Relations
--
--
Ms. Elizabeth S. (Betsy) Hanna
Ms. Elizabeth S. (Betsy) Hanna
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
516.36K
+4.86%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
62.40K
-0.33%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
40.90K
+140.86%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
25.00K
-6.14%
Mr. Gaetano Guglielmino
Mr. Gaetano Guglielmino
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. John T. Treace
Mr. John T. Treace
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--

收入明細

暫無數據
暫無數據
業務
地區
暫無數據

股東統計

更新時間: 8月16日 週六
更新時間: 8月16日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Treace (John T.)
18.37%
Armistice Capital LLC
9.82%
BlackRock Institutional Trust Company, N.A.
5.15%
William Blair Investment Management, LLC
4.87%
The Vanguard Group, Inc.
4.29%
其他
57.50%
持股股東
持股股東
佔比
Treace (John T.)
18.37%
Armistice Capital LLC
9.82%
BlackRock Institutional Trust Company, N.A.
5.15%
William Blair Investment Management, LLC
4.87%
The Vanguard Group, Inc.
4.29%
其他
57.50%
股東類型
持股股東
佔比
Individual Investor
25.47%
Investment Advisor/Hedge Fund
22.16%
Hedge Fund
18.29%
Investment Advisor
16.74%
Research Firm
2.66%
Bank and Trust
0.30%
Pension Fund
0.04%
Family Office
0.03%
Insurance Company
0.03%
其他
14.29%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
338
38.30M
60.11%
-18.99M
2025Q2
369
55.28M
87.88%
-20.58M
2025Q1
378
54.40M
86.48%
-21.10M
2024Q4
366
54.35M
86.91%
-21.27M
2024Q3
360
58.92M
95.05%
-18.98M
2024Q2
346
57.87M
93.51%
-12.18M
2024Q1
319
59.01M
95.72%
-10.84M
2023Q4
318
57.97M
94.48%
-4.76M
2023Q3
299
57.85M
94.48%
-5.12M
2023Q2
290
57.64M
94.33%
-3.44M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Treace (John T.)
11.70M
18.53%
-159.07K
-1.34%
Mar 24, 2025
Armistice Capital LLC
6.26M
9.91%
+49.00K
+0.79%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.28M
5.2%
-119.04K
-3.50%
Jun 30, 2025
William Blair Investment Management, LLC
3.10M
4.91%
+39.28K
+1.28%
Jun 30, 2025
The Vanguard Group, Inc.
2.73M
4.31%
+20.22K
+0.75%
Jun 30, 2025
Gagnon Securities LLC
2.25M
3.56%
-459.82K
-16.97%
Jun 30, 2025
Treace (James T)
1.78M
2.82%
--
--
Mar 24, 2025
CIBC Private Wealth Management
1.69M
2.67%
-606.00K
-26.42%
Jun 30, 2025
Millennium Management LLC
1.52M
2.4%
+1.07M
+241.03%
Jun 30, 2025
JP Morgan Asset Management
1.30M
2.05%
-101.61K
-7.26%
Jun 30, 2025
查看更多

持股ETF

更新時間: 11月6日 週四
更新時間: 11月6日 週四
機構名稱
佔比
iShares U.S. Medical Devices ETF
0.04%
Franklin US Small Cap Multifactor Index ETF
0.04%
iShares Russell 2000 Growth ETF
0.02%
Fidelity Enhanced Small Cap ETF
0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
iShares Russell 2000 ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Schwab U.S. Small-Cap ETF
0.01%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
查看更多
iShares U.S. Medical Devices ETF
佔比0.04%
Franklin US Small Cap Multifactor Index ETF
佔比0.04%
iShares Russell 2000 Growth ETF
佔比0.02%
Fidelity Enhanced Small Cap ETF
佔比0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
佔比0.01%
iShares Russell 2000 ETF
佔比0.01%
ProShares UltraPro Russell2000
佔比0.01%
Schwab U.S. Small-Cap ETF
佔比0.01%
Global X Russell 2000 ETF
佔比0.01%
ProShares Hedge Replication ETF
佔比0.01%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
KeyAI